Top Industry Stories – July 22, 2009 « Medical Dynamics

THE LATEST WORD

Top Industry Stories – July 22, 2009

Posted on July 22nd, 2009 | by Rxmedyn | No Comments »

“Europe stocks turn positive; drugmakers rise” (Reuters)
“Onyx Surges, Nexavar Fights Breast Cancer in Study” (Bloomberg)
“GlaxoSmithKline Completes Acquisition of Stiefel” (Press release issued by GlaxoSmithKline, PRNewswire)
“Drugmaker GSK says making ‘rapid progress’ on swine flu vaccine” (AFP)
“Drug companies post solid results, offer bullish view” (Reuters)
“Generic Cos: We Can’t Support Current US Biologic Legislation” (Dow Jones Newswires)
“Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies” (Press release issued by Novavax, PRNewswire)
“Pfizer Earnings Drop 19% as Lilly Net Rises 21%” (Wall Street Journal)
“GlaxoSmithKline up 11 percent on emerging markets” (Chicago Tribune)
“Genzyme Delivers Solid Second-Quarter Financial Results” (Press release issued by Genzyme, Genzyme.com)
“Chugai seeks approval for renal anaemia drug” (Reuters)
“Lobbying Spending Rises Only Slightly Amid Health Overhaul” (Wall Street Journal)
“For Merck, Asthma Drug Helps Offset Earnings Fall” (Reuters)
“Costly Drugs Known as Biologics Prompt Exclusivity Debate” (The New York Times)
“Epix Pharmaceuticals is latest biotech to fall” (Boston Globe)
“Depomed Provides License for Patents Covering Metformin Extended Release Technology to Merck & Co., Inc.” (Press release issued by Depomed, Business Wire)
“Lonza H1 profit falls 33 percent, meets forecast” (Reuters)
“Bayer says Nexavar shows promise in breast cancer” (Reuters)

Posted in Industry Stories

Leave a Reply

You must be logged in to post a comment.